Corporate news

Organic revenue growth of 16.6% in first half of 2023 Adjusted EBITDA up 23.0% organically Production capacities expanded in Europe, the United…

Dividend of EUR 1.25 per share after strong financial year 2022 High approval rates for all agenda items Forecast reaffirmed: double-digit growth…

3.14 million new shares placed at EUR 86.50 with gross proceeds of EUR 271.6 million Strong investor demand underlines support for formula G…

Duesseldorf, April 18, 2023 – Today, the management board of Gerresheimer AG (ISIN DE000A0LD6E6), with the approval of the supervisory board, resolved…

First-quarter revenues grew organically by 21.0% Adjusted EBITDA up organically by 24.8% Gerresheimer confirms guidance for financial year 2023  …

Gerresheimer AG, Duesseldorf, invites tenders for the mandate to audit the Annual Financial Statements and Consolidated Financial Statements as well…

Consistent execution of strategy and strong fourth quarter performance has resulted in organic revenue growth of 16.2% for FY 2022 Organic growth…

Düsseldorf, Germany, February 8, 2023. Gerresheimer AG, the leading global provider of healthcare, beauty, and drug delivery systems for pharma,…

– Top rating recognizes commitment to creating a positive impact on climate change Duesseldorf, January 19th 2023 – Gerresheimer AG, a leading…